Which agent is described as a partial agonist at D2, D3 with high affinity for 5-HT1A and is a newer member of this class?

Prepare for the Schizophrenia and Psychotic Disorders Test. Enhance your learning with flashcards and multiple choice questions. Each question includes detailed explanations and important insights. Get ready to excel in your exam!

Multiple Choice

Which agent is described as a partial agonist at D2, D3 with high affinity for 5-HT1A and is a newer member of this class?

Explanation:
Brexpiprazole fits this description because it belongs to the class of dopamine D2/D3 partial agonists with significant activity at serotonin receptors. It acts as a partial agonist at D2 and D3, which provides antipsychotic effects with a lower risk of extrapyramidal symptoms compared with full D2 antagonists. It also has high affinity for 5-HT1A receptors, meaning it can produce serotonin-1A–mediated effects that can help with mood and anxiety symptoms and may contribute to a broader therapeutic profile. Additionally, brexpiprazole is a newer member of this class, introduced after the older agents like aripiprazole, and it includes potent 5-HT2A antagonism that can help with negative symptoms and cognitive aspects. In contrast, other choices either are not partial agonists at D2/D3, or they don’t emphasize the high 5-HT1A affinity as clearly, or are not the newer member of this class.

Brexpiprazole fits this description because it belongs to the class of dopamine D2/D3 partial agonists with significant activity at serotonin receptors. It acts as a partial agonist at D2 and D3, which provides antipsychotic effects with a lower risk of extrapyramidal symptoms compared with full D2 antagonists. It also has high affinity for 5-HT1A receptors, meaning it can produce serotonin-1A–mediated effects that can help with mood and anxiety symptoms and may contribute to a broader therapeutic profile. Additionally, brexpiprazole is a newer member of this class, introduced after the older agents like aripiprazole, and it includes potent 5-HT2A antagonism that can help with negative symptoms and cognitive aspects. In contrast, other choices either are not partial agonists at D2/D3, or they don’t emphasize the high 5-HT1A affinity as clearly, or are not the newer member of this class.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy